A role of peripheral myelin protein 2 in lipid homeostasis of myelinating Schwann cells

GLIA

Volumn 62, Issue 9, 2014, Pages 1502-1512

  Zenker, Jennifer ^a   Stettner, Mark ^b   Ruskamo, Salla ^c   Domènech Estévez, Enric ^a   Baloui, Hasna ^a   Médard, Jean Jacques ^a   Verheijen, Mark H G ^d   Brouwers, Jos F ^e   Kursula, Petri ^c,f   Kieseier, Bernd C ^b   Chrast, Roman ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF OULU   (Finland)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

^f UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Fatty acid transport; Glia; Myelin basic protein; Peripheral nervous system; Pmp2

Indexed keywords

MYELIN PROTEIN; PERIPHERAL MYELIN PROTEIN 2; UNCLASSIFIED DRUG; FATTY ACID; MBP PROTEIN, MOUSE; MESSENGER RNA; MYELIN BASIC PROTEIN; PMP2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LIPID HOMEOSTASIS; MALE; MOTOR NERVE CONDUCTION; MOUSE; MYELINATION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN STRUCTURE; SCHWANN CELL; ANIMAL; C3H MOUSE; C57BL MOUSE; CELL MEMBRANE; GENETICS; HOMEOSTASIS; KNOCKOUT MOUSE; METABOLISM; MYELIN SHEATH; NERVE CONDUCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; SCIATIC NERVE;

ANIMALS; CELL MEMBRANE; FATTY ACIDS; HOMEOSTASIS; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN BASIC PROTEIN; MYELIN P2 PROTEIN; MYELIN SHEATH; NEURAL CONDUCTION; PHENOTYPE; RNA, MESSENGER; SCHWANN CELLS; SCIATIC NERVE;

EID: 84904310811     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22696     Document Type: Article

References (50)

1. Arnaud E, Zenker J, de Preux Charles AS, Stendel C, Roos A, Medard JJ, Tricaud N, Kleine H, Luscher B, Weis J, Suter U, Senderek J, Chrast R 2009. SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system. Proc Natl Acad Sci USA 106:17528-17533.
2. Bermingham JR Jr, Shumas S, Whisenhunt T, Sirkowski EE, O'Connell S, Scherer SS, Rosenfeld MG. 2002. Identification of genes that are downregulated in the absence of the POU domain transcription factor pou3f1 (Oct-6, Tst-1, SCIP) in sciatic nerve. J Neurosci 22:10217-10231.
3. Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917.
4. Brouwers JF, Aalberts M, Jansen JW, van Niel G, Wauben MH, Stout TA, Helms JB, Stoorvogel W. 2013. Distinct lipid compositions of two types of human prostasomes. Proteomics 13:1660-1666.
5. Cartoni R, Arnaud E, Medard JJ, Poirot O, Courvoisier DS, Chrast R, Martinou JC. 2010. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-tooth neuropathy type 2A. Brain 133:1460-1469.
6. Chrast R, Saher G, Nave KA, Verheijen MH. 2011. Lipid metabolism in myelinating glial cells: Lessons from human inherited disorders and mouse models. J Lipid Res 52:419-434.
7. Davies JK, Thumser AE, Wilton DC. 1999. Binding of recombinant rat liver fatty acid-binding protein to small anionic phospholipid vesicles results in ligand release: A model for interfacial binding and fatty acid targeting. Biochemistry 38:16932-16940.
8. de Preux Charles AS, Verdier V, Zenker J, Peter B, Medard JJ, Kuntzer T, Beckmann JS, Bergmann S, Chrast R. 2010. Global transcriptional programs in peripheral nerve endoneurium and DRG are resistant to the onset of type 1 diabetic neuropathy in Ins2 mice. PLoS One 5:e10832.
9. Dupouey P, Jacque C, Bourre JM, Cesselin F, Privat A, Baumann N. 1979. Immunochemical studies of myelin basic protein in shiverer mouse devoid of major dense line of myelin. Neurosci Lett 12:113-118.
10. Falomir-Lockhart LJ, Laborde L, Kahn PC, Storch J, Corsico B. 2006. Protein-membrane interaction and fatty acid transfer from intestinal fatty acid-binding protein to membranes. Support for a multistep process. J Biol Chem 281:13979-13989.
11. Furuhashi M, Hotamisligil GS. 2008. Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7:489-503.
12. Garbay B, Heape AM, Sargueil F, Cassagne C. 2000. Myelin synthesis in the peripheral nervous system. Prog Neurobiol 61:267-304.
13. Gillespie CS, Trapp BD, Colman DR, Brophy PJ. 1990. Distribution of myelin basic protein and P2 mRNAs in rabbit spinal cord oligodendrocytes. J Neurochem 54:1556-1561.
14. Gould RM, Byrd AL, Barbarese E. 1995. The number of Schmidt-Lanterman incisures is more than doubled in shiverer PNS myelin sheaths. J Neurocytol 24:85-98.
15. Greenfield S, Brostoff S, Eylar EH, Morell P. 1973. Protein composition of myelin of the peripheral nervous system. J Neurochem 20:1207-1216.
16. Hahn AF, Whitaker JN, Kachar B, Webster HD. 1987. P2, P1, and P0 myelin protein expression in developing rat sixth nerve: A quantitative immunocytochemical study. J Comp Neurol 260:501-512.
17. Han H, Myllykoski M, Ruskamo S, Wang C, Kursula P. 2013. Myelin-specific proteins: A structurally diverse group of membrane-interacting molecules. Biofactors 39:233-241.
18. Inouye H, Ganser AL, Kirschner DA. 1985. Shiverer and normal peripheral myelin compared: Basic protein localization, membrane interactions, and lipid composition. J Neurochem 45:1911-1922.
19. Kadlubowski M, Hughes RA, Gregson NA. 1980. Experimental allergic neuritis in the Lewis rat: Characterization of the activity of peripheral myelin and its major basic protein, P2. Brain Res 184:439-454.
20. Kadlubowski M, Hughes RA, Gregson NA. 1984. Spontaneous and experimental neuritis and the distribution of the myelin protein P2 in the nervous system. J Neurochem 42:123-129.
21. Kirschner DA, Ganser AL. 1980. Compact myelin exists in the absence of basic protein in the shiverer mutant mouse. Nature 283:207-210.
22. Knoll W, Natali F, Peters J, Nanekar R, Wang C, Kursula P. 2010. Dynamic properties of a reconstituted myelin sheath. Spectrosc Int J 24:585-592.
23. LeBlanc AC, Poduslo JF. 1990. Axonal modulation of myelin gene expression in the peripheral nerve. J Neurosci Res 26:317-326.
24. Maddalo G, Shariatgorji M, Adams CM, Fung E, Nilsson U, Zubarev RA, Sedzik J, Ilag LL. 2010. Porcine P2 myelin protein primary structure and bound fatty acids determined by mass spectrometry. Anal Bioanal Chem 397:1903-1910.
25. Majava V, Polverini E, Mazzini A, Nanekar R, Knoll W, Peters J, Natali F, Baumgartel P, Kursula I, Kursula P. 2010. Structural and functional characterization of human peripheral nervous system myelin protein P2. PLoS One 5:e10300.
26. Martini R, Mohajeri MH, Kasper S, Giese KP, Schachner M. 1995a. Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J Neurosci 15:4488-4495.
27. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M. 1995b. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet 11:281-286.
28. Mikoshiba K, Kohsaka S, Takamatsu K, Tsukada Y. 1981. Neurochemical and morphological studies on the myelin of peripheral nervous system from Shiverer mutant mice: Absence of basic proteins common to central nervous system. Brain Res 204:455-460.
29. Mikoshiba K, Takamatsu K, Tsukada Y. 1983. Peripheral nervous system of shiverer mutant mice: Developmental change of myelin components and immunohistochemical demonstration of the absence of MBP and presence of P2 protein. Brain Res 283:71-79.
30. Mitchell LS, Griffiths IR, Morrison S, Barrie JA, Kirkham D, Mcphilemy K. 1990. Expression of myelin protein gene transcripts by Schwann-cells of regenerating nerve. J Neurosc Res 27:125-135.
31. Monuki ES, Weinmaster G, Kuhn R, Lemke G. 1989. SCIP: A glial POU domain gene regulated by cyclic AMP. Neuron 3:783-793.
32. Nadra K, de Preux Charles AS, Medard JJ, Hendriks WT, Han GS, Gres S, Carman GM, Saulnier-Blache JS, Verheijen MH, Chrast R. 2008. Phosphatidic acid mediates demyelination in Lpin1 mutant mice. Genes Dev 22:1647-1661.
33. Narayanan V, Kaestner KH, Tennekoon GI. 1991. Structure of the mouse myelin P2 protein gene. J Neurochem 57:75-80.
34. Patzig J, Jahn O, Tenzer S, Wichert SP, de Monasterio-Schrader P, Rosfa S, Kuharev J, Yan K, Bormuth I, Bremer J, Aquzzi A, Orfaniotou F, Hesse D, Schwab MH, Möbius W, Nave KA, Werner HB 2011. Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J Neurosci 31:16369-16386.
35. Rostami A, Brown MJ, Lisak RP, Sumner AJ, Zweiman B, Pleasure DE. 1984. The role of myelin P2 protein in the production of experimental allergic neuritis. Ann Neurol 16:680-685.
36. Ruskamo S, Yadav RP, Sharma S, Lehtimaki M, Laulumaa S, Aggarwal S, Simons M, Burck J, Ulrich AS, Juffer AH, Kursula I, Kursula P 2014. Atomic resolution view into the structure-function relationships of the human myelin peripheral membrane protein P2. Acta Crystallogr D Biol Crystallogr 70:165-176.
37. Sakai K, Miyazaki J. 1997. A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem Biophys Res Commun 237:318-324.
38. Salzer JL, Brophy PJ, Peles E. 2008. Molecular domains of myelinated axons in the peripheral nervous system. Glia 56:1532-1540.
39. Sedzik J, Blaurock AE, Hoechli M. 1985. Reconstituted P2/myelin-lipid multilayers. J Neurochem 45:844-852.
40. Sedzik J, Jastrzebski JP. 2011. High-resolution structural model of porcine P2 myelin membrane protein with associated fatty acid ligand: Fact or artifact? J Neurosci Res 89:909-920.
41. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G. 2006. XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78:779-787.
42. Stacklies W, Redestig H, Scholz M, Walther D, Selbig J. 2007. pcaMethods-A bioconductor package providing PCA methods for incomplete data. Bioinformatics 23:1164-1167.
43. Suresh S, Wang C, Nanekar R, Kursula P, Edwardson JM. 2010. Myelin basic protein and myelin protein 2 act synergistically to cause stacking of lipid bilayers. Biochemistry 49:3456-3463.
44. Suter U, Scherer SS. 2003. Disease mechanisms in inherited neuropathies. Nat Rev Neurosci 4:714-726.
45. Trapp BD, Dubois-Dalcq M, Quarles RH. 1984. Ultrastructural localization of P2 protein in actively myelinating rat Schwann cells. J Neurochem 43:944-948.
46. Trapp BD, McIntyre LJ, Quarles RH, Sternberger NH, Webster HD. 1979. Immunocytochemical localization of rat peripheral nervous system myelin proteins: P2 protein is not a component of all peripheral nervous system myelin sheaths. Proc Natl Acad Sci USA 76:3552-3556.
47. Uyemura K, Yoshimura K, Suzuki M, Kitamura K. 1984. Lipid binding activities of the P2 protein in peripheral nerve myelin. Neurochem Res 9:1509-1514.
48. Verdier V, Csardi G, de Preux-Charles AS, Medard JJ, Smit AB, Verheijen MH, Bergmann S, Chrast R. 2012. Aging of myelinating glial cells predominantly affects lipid metabolism and immune response pathways. Glia 60:751-760.
49. Wilkinson TC, Wilton DC. 1987. Studies on fatty acid-binding proteins. The binding properties of rat liver fatty acid-binding protein. Biochem J 247:485-488.
50. Winter J. 1982. Shiverer peripheral myelin contains P2. Nature 298:471-472.